C12Y 503/02001
Phenylpyruvate tautomerase
Official title: Phenylpyruvate tautomerase (5.3.2.1)
C12Y503/02001 (Phenylpyruvate tautomerase) appears on 4 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 11
- Assignees
- 6
- Inventors
- 8
- Latest grant
- 29 Dec 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Method of inhibiting binding or activity of MIF by administering a MIF antagonist29 Dec 2015US 9,221,903 B2Baxalta Incorporated
- MIF antagonists15 Jul 2014US 8,779,099 B2Baxter Healthcare S. A.
- Method of inhibiting binding or activity of MIF by administering a MIF antagonist31 Dec 2013US 8,617,822 B2Baxter Healthcare S. A.
- Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor22 Jun 2010US 7,741,057 B2Cytokine PharmaSciences, Inc.
- Novel recombinant strain of mycobacterium smegmatis and use of same23 May 2024US 2024/0165216 A1Clipsbnc Co., Ltd.
- Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor19 Apr 2018US 2018/0105593 A1Baxalta Incorporated
- Method of inhibiting binding or activity of mif by administering a mif antagonist2 Jun 2016US 2016/0152708 A1Baxalta Incorporated
- Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor8 Jan 2015US 2015/0010570 A1Baxter Healthcare S. A.
- Method of inhibiting binding or activity of mif by administering a mif antagonist26 Jun 2014US 2014/0178403 A1Baxter Healthcare S. A.
Most cited
By later US patents
- Method of inhibiting binding or activity of MIF by administering a MIF antagonist2US 8,617,822 B2Baxter Healthcare S. A. · 2013
- Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor1US 7,741,057 B2Cytokine PharmaSciences, Inc. · 2010